According to Tonix Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.1555.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.2238 | 106.79% |
2022-12-31 | 0.1083 | -86.66% |
2021-12-31 | 0.8116 | -45.01% |
2020-12-31 | 1.48 | 39.24% |
2019-12-31 | 1.06 | 250.6% |
2018-12-31 | 0.3023 | -72.45% |
2017-12-31 | 1.10 | 51.1% |
2016-12-31 | 0.7263 | -79.75% |
2015-12-31 | 3.59 | 105.19% |
2014-12-31 | 1.75 | -81.04% |
2013-12-31 | 9.22 | -62.77% |
2012-12-31 | 24.8 | |
2011-12-31 | N/A | |
2010-12-31 | N/A | |
2009-12-31 | N/A | |
2008-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Eagle Pharmaceuticals
EGRX | 0.2334 | 50.15% | ๐บ๐ธ USA |